a developer of endoscopic procedures and devices
Industry MedicalSpecialties
A.I.dvisor tells us that XYLO and LH have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XYLO and LH's prices will move in lockstep.
| Ticker / NAME | Correlation To XYLO | 1D Price Change % | ||
|---|---|---|---|---|
| XYLO | 100% | -2.74% | ||
| LH - XYLO | 27% Poorly correlated | +0.80% | ||
| PMD - XYLO | 24% Poorly correlated | +0.43% | ||
| CNMD - XYLO | 23% Poorly correlated | +1.18% | ||
| SKHHY - XYLO | 23% Poorly correlated | -5.06% | ||
| ESTA - XYLO | 23% Poorly correlated | -7.22% | ||
More | ||||
| Ticker / NAME | Correlation To XYLO | 1D Price Change % |
|---|---|---|
| XYLO | 100% | -2.74% |
| Medical Specialties category (428 stocks) | 14% Poorly correlated | -1.28% |
| Medical Specialties category (418 stocks) | 14% Poorly correlated | -1.48% |
| middle east category (69 stocks) | 11% Poorly correlated | -0.72% |